Inherited human ZNF341 deficiency

[1]  R. Sherkat,et al.  Ciliary and immune dysfunctions and their genetic background in patients with non-cystic fibrosis bronchiectasis in Central Iran , 2022, Irish Journal of Medical Science (1971 -).

[2]  B. Garty,et al.  Hyper IgE Syndrome in an Isolated Population in Israel , 2022, Frontiers in Immunology.

[3]  Xiaoying Hu,et al.  The JAK/STAT signaling pathway: from bench to clinic , 2021, Signal Transduction and Targeted Therapy.

[4]  J. Casanova,et al.  Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency , 2021, The Journal of Immunology.

[5]  J. Casanova,et al.  Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance , 2021, The Journal of experimental medicine.

[6]  A. Gennery,et al.  STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions , 2021, Journal of Clinical Immunology.

[7]  R. Uppuluri,et al.  Clinical Profile of Hyper-IgE Syndrome in India , 2021, Frontiers in Immunology.

[8]  J. Casanova,et al.  Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance , 2021, Proceedings of the National Academy of Sciences.

[9]  Jinqiao Sun,et al.  The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations , 2020, Allergy, Asthma & Clinical Immunology.

[10]  Liping Jiang,et al.  Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009‐2018) , 2020, Scandinavian journal of immunology.

[11]  David R. Murdock,et al.  Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome , 2020, The Journal of experimental medicine.

[12]  A. Puel Human inborn errors of immunity underlying superficial or invasive candidiasis , 2020, Human Genetics.

[13]  J. Casanova,et al.  Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome , 2020, Journal of Clinical Immunology.

[14]  D. Gisselsson,et al.  Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome , 2020, The Journal of experimental medicine.

[15]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[16]  L. Dotta,et al.  Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and/or neonatal rash: Evidence from the Italian cohort of 61 patients with elevated IgE. , 2019, The journal of allergy and clinical immunology. In practice.

[17]  Kenneth G. C. Smith,et al.  Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses , 2019, The Journal of experimental medicine.

[18]  N. Rezaei,et al.  The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long‐term follow‐up and genetic analysis , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[19]  I. Tezcan,et al.  Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function , 2018, Haematologica.

[20]  J. Casanova,et al.  Human hyper-IgE syndrome: singular or plural? , 2018, Mammalian Genome.

[21]  D. Chaussabel,et al.  A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity , 2018, Science Immunology.

[22]  A. Schäffer,et al.  ZNF341 controls STAT3 expression and thereby immunocompetence , 2018, Science Immunology.

[23]  S. Holland,et al.  A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis , 2017, The Journal of experimental medicine.

[24]  S. Holland,et al.  Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome , 2017, Journal of Clinical Immunology.

[25]  Tong-Xin Chen,et al.  Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review , 2017, Journal of Clinical Immunology.

[26]  J. Casanova,et al.  Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency , 2016, Proceedings of the National Academy of Sciences.

[27]  Andrew Emili,et al.  Multiparameter functional diversity of human C2H2 zinc finger proteins , 2016, Genome research.

[28]  C. Cunningham-Rundles,et al.  Hemoptysis in a Patient with Elevated Immunoglobulin E. , 2016, The journal of allergy and clinical immunology. In practice.

[29]  Lluis Quintana-Murci,et al.  The mutation significance cutoff: gene-level thresholds for variant predictions , 2016, Nature Methods.

[30]  J. Casanova,et al.  STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function , 2015, The Journal of experimental medicine.

[31]  O. Sanal,et al.  Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R , 2015, Haematologica.

[32]  Anna Lindstrand,et al.  Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. , 2015, American journal of human genetics.

[33]  Joshua L. Deignan,et al.  De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. , 2015, American journal of human genetics.

[34]  M. Seidl,et al.  Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency , 2015, Haematologica.

[35]  J. Colinge,et al.  Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. , 2014, The Journal of allergy and clinical immunology.

[36]  R. Carpenter,et al.  STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation With STAT3 , 2013, Molecular carcinogenesis.

[37]  A. Hoischen,et al.  Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis , 2013, Molecular genetics & genomic medicine.

[38]  J. Casanova,et al.  Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function. , 2013, The Journal of allergy and clinical immunology.

[39]  A. Schäffer,et al.  Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome , 2013, The Journal of experimental medicine.

[40]  J. Casanova,et al.  Dominant‐negative STAT1 SH2 domain mutations in unrelated patients with mendelian susceptibility to mycobacterial disease , 2012, Human mutation.

[41]  A. Fischer,et al.  Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey , 2012, Medicine.

[42]  Zuoming Sun,et al.  Protein Kinase C-θ Promotes Th17 Differentiation via Upregulation of Stat3 , 2012, The Journal of Immunology.

[43]  J. Casanova,et al.  Functional STAT3 deficiency compromises the generation of human T follicular helper cells. , 2012, Blood.

[44]  A. Fischer,et al.  Frequent and Widespread Vascular Abnormalities in Human Signal Transducer and Activator of Transcription 3 Deficiency , 2012, Circulation. Cardiovascular genetics.

[45]  S. Holland,et al.  A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. , 2011, Immunity.

[46]  Sven Kreiborg,et al.  Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. , 2011, American journal of human genetics.

[47]  Sami Al-Hajjar,et al.  B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans , 2010, The Journal of experimental medicine.

[48]  J. Casanova,et al.  A partial form of recessive STAT1 deficiency in humans. , 2009, The Journal of clinical investigation.

[49]  H. Takada,et al.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.

[50]  J. Casanova,et al.  Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease , 2006, PLoS genetics.

[51]  A. Munnich,et al.  Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. , 2004, American journal of human genetics.

[52]  Sami Al-Hajjar,et al.  Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency , 2003, Nature Genetics.

[53]  J. Miyazaki,et al.  Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells , 2001, Molecular and Cellular Biology.

[54]  Steven M. Holland,et al.  Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.

[55]  T. Hirano,et al.  Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein* , 1998, The Journal of Biological Chemistry.

[56]  R. Buckley,et al.  EXTREME HYPERIMMUNOGLOBULINEMIA E AND UNDUE SUSCEPTIBILITY TO INFECTION , 1972, Pediatrics.

[57]  J. Schaller,et al.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. , 1966 .